Shandong Buchang Pharmaceuticals announced that its holding subsidiary Zhejiang Tianyuan Biopharmaceutical Co., Ltd.'s application for the clinical trial registration of the "varicella attenuated live vaccine" has been accepted by the National Medical Products Administration.
步长制药：控股子公司药品临床试验取得受理通知书
Shandong Buchang Pharmaceuticals: The holding subsidiary's pharmaceutical clinical trial has received an acceptance notice.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated